Table 1 Characteristics of study patients in demographics and clinical message at baseline
Characteristic | n (%) | Groups of Cpn IgA (n = 82) | χ2 | P | Groups of Cpn IgG (n = 82) | χ2 | P | Groups of Cpn IgAIgG (n = 82) | χ2 | P | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cpn IgA − n (%) | Cpn IgA + n (%) | Cpn IgG − n (%) | Cpn IgG + n (%) | Cpn IgA − IgG − n (%) | Cpn IgA + IgG − /IgA − IgG + n (%) | Cpn IgA + IgG + n (%) | ||||||||
Gender | 4.523 | 0.033 | 0.164 | 0.686 | 5.908 | 0.052 | ||||||||
Male | 46(56.1) | 30 (66.7) | 16 (43.2) | 12 (60.0) | 34 (54.8) | 10 (58.8) | 22 (71.0) | 14 (41.2) | ||||||
Female | 36(43.9) | 15 (33.3) | 21 (56.8) | 8 (40.0) | 28 (45.2) | 7 (41.2) | 9 (29.0) | 20 (58.8) | ||||||
Age | 1.057 | 0.304 | 1.042 | 0.307 | 0.204 | 0.903 | ||||||||
< = 60 | 45(54.9) | 27 (60.0) | 18 (48.6) | 9 (45.0) | 36 (58.1) | 9 (52.9) | 18 (58.1) | 18 (52.9) | ||||||
> 60 | 37(45.1) | 18 (40.0) | 19 (51.4) | 11 (55.0) | 26 (41.9) | 8 (47.1) | 13 (41.9) | 16 (47.1) | ||||||
BMI | 0.925 | 0.823 | 0.861 | |||||||||||
< 18.5 | 3 (3.7) | 2 (4.4) | 1 (2.7) | 1 (5.0) | 2 (3.2) | 1 (5.9) | 1 (3.2) | 1 (2.9) | ||||||
[18.5, 24) | 48(58.5) | 27 (60.0) | 21 (56.8) | 11 (55.0) | 37 (59.7) | 9 (52.9) | 20 (64.5) | 19 (55.9) | ||||||
> = 24 | 31(37.8) | 16 (35.6) | 15 (40.5) | 8 (40.0) | 23 (37.1) | 7 (41.2) | 10 (32.3) | 14 (41.2) | ||||||
Educational level | 0.023 | 0.879 | 2.726 | 0.099 | 2.875 | 0.238 | ||||||||
Primary and below | 48(59.3) | 27 (60.0) | 21 (58.3) | 15 (75.0) | 33 (54.1) | 13 (76.5) | 16 (51.6) | 19 (57.6) | ||||||
Junior high school and above | 33(40.7) | 18 (40.0) | 15 (41.7) | 5 (25.0) | 28 (45.9) | 4 (23.5) | 15 (48.4) | 14 (42.4) | ||||||
Smoker | 0.912 | 0.340 | 0.142 | 0.706 | 1.802 | 0.406 | ||||||||
No | 44(53.7) | 22 (48.9) | 22 (59.5) | 10 (50.0) | 34 (54.8) | 9 (52.9) | 14 (45.2) | 21 (61.8) | ||||||
Yes | 38(46.3) | 23 (51.1) | 15 (40.5) | 10 (50.0) | 28 (45.2) | 8 (47.1) | 17 (54.8) | 13 (38.2) | ||||||
Drinker | 0.931 | 0.335 | 2.337 | 0.126 | 0.262 | |||||||||
No | 60(73.2) | 31 (68.9) | 29 (78.4) | 12 (60.0) | 48 (77.4) | 11 (64.7) | 21 (67.7) | 28 (82.4) | ||||||
Yes | 22(26.8) | 14 (31.1) | 8 (21.6) | 8 (40.0) | 14 (22.6) | 6 (35.3) | 10 (32.3) | 6 (17.6) | ||||||
Histological type | 0.277 | 0.599 | 0.063 | 0.802 | 0.656 | |||||||||
Non-adenocarcinoma | 22(27.2) | 13 (29.5) | 9 (24.3) | 5 (25.0) | 17 (27.9) | 4 (23.5) | 10 (33.3) | 8 (23.5) | ||||||
Adenocarcinoma | 59(72.8) | 31 (70.5) | 28 (75.7) | 15 (75.0) | 44 (72.1) | 13 (76.5) | 20 (66.7) | 26 (76.5) | ||||||
TNM stage | 0.647 | 0.421 | 1.739 | 0.187 | 0.823 | 0.663 | ||||||||
0 and I | 47(57.3) | 24 (53.3) | 23 (62.2) | 14 (70.0) | 33 (53.2) | 11 (64.7) | 16 (51.6) | 20 (58.8) | ||||||
II and above | 35(42.7) | 21 (46.7) | 14 (37.8) | 6 (30.0) | 29 (46.8) | 6 (35.3) | 15 (48.4) | 14 (41.2) | ||||||
Maximum diameter of tumor | 0.115 | 0.735 | 0.163 | 0.686 | 0.972 | 0.615 | ||||||||
≤ 2.0 | 31(40.8) | 16 (39.0) | 15 (42.9) | 7 (36.8) | 24 (42.1) | 5 (31.2) | 13 (46.4) | 13 (40.6) | ||||||
> 2.0 | 45(59.2) | 25 (61.0) | 20 (57.1) | 12 (63.2) | 33 (57.9) | 11 (68.8) | 15 (53.6) | 19 (59.4) | ||||||
Therapeutic Method | 0.003 | 0.348 | 0.009 | |||||||||||
Untreated | 2 (2.4) | 1 (2.2) | 1 (2.7) | 0 (0.0) | 2 (3.2) | 0 (0.0) | 1 (3.2) | 1 (2.9) | ||||||
Surgery alone | 54(65.9) | 23 (51.1) | 31 (83.8) | 13 (65.0) | 41 (66.1) | 10 (58.8) | 16 (51.6) | 28 (82.4) | ||||||
Chemotherapy/radiation alone | 6 (7.3) | 6 (13.3) | 0 (0.0) | 0 (0.0) | 6 (9.7) | 0 (0.0) | 6 (19.4) | 0 (0.0) | ||||||
Treated with both chemotherapy/radiation and surgery | 20(24.4) | 15 (33.3) | 5 (13.5) | 7 (35.0) | 13 (21.0) | 7 (41.2) | 8 (25.8) | 5 (14.7) | ||||||